Clinuvel Pharmaceuticals Balance Sheet

Financials in millions AUD. Fiscal year is July - June.

Millions AUD. Fiscal year is Jul - Jun.

Fiscal Year	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021
Period Ending	Jun '25 Jun 30, 2025	Jun '24 Jun 30, 2024	Jun '23 Jun 30, 2023	Jun '22 Jun 30, 2022	Jun '21 Jun 30, 2021
Cash & Equivalents	28.02	35.2	31.89	121.51	82.69
Short-Term Investments	196.09	148.67	124.92	-	-
Cash & Short-Term Investments	224.11	183.87	156.81	121.51	82.69
Cash Growth	21.88%	17.25%	29.05%	46.94%	23.89%
Accounts Receivable	24.17	25.01	20.64	15.9	15.81
Other Receivables	3.3	1.23	1.57	0.3	0.28
Receivables	27.46	26.24	22.21	16.2	16.09
Inventory	8.82	10.63	9.52	1.83	3.19
Prepaid Expenses	-	-	-	1.04	0.88
Other Current Assets	2.58	1.33	1.07	-	-
Total Current Assets	262.97	222.06	189.62	140.58	102.85
Property, Plant & Equipment	7.13	7.72	2.85	2.7	2.6
Long-Term Investments	0.21	0.13	-	-	-
Goodwill	-	-	-	0.19	0.19
Other Intangible Assets	0.19	0.19	0.19	-	-
Long-Term Deferred Tax Assets	1.26	1.02	1.06	0.48	2.93
Total Assets	271.75	231.12	193.71	143.95	108.57
Accounts Payable	2.55	2.35	2.79	0.26	4.66
Accrued Expenses	2.29	1.88	1.45	2.86	3.7
Current Portion of Leases	0.43	0.37	0.3	0.32	0.26
Current Income Taxes Payable	14.55	15.85	16.09	7.28	0.1
Other Current Liabilities	7.39	4.76	4.86	3.02	-
Total Current Liabilities	27.21	25.21	25.49	13.73	8.71
Long-Term Leases	0.1	0.51	0.7	0.94	1.05
Pension & Post-Retirement Benefits	0.13	0.08	0.06	0.03	0.01
Long-Term Deferred Tax Liabilities	3.42	2.23	2.76	3.62	-
Other Long-Term Liabilities	0.09	0.08	0.07	0.07	0.06
Total Liabilities	30.94	28.11	29.08	18.39	9.83
Common Stock	169.28	168.8	151.85	151.85	151.85
Retained Earnings	63.63	29.96	-9.77	-38.4	-58.13
Comprehensive Income & Other	7.9	4.25	22.56	12.11	5.02
Total Common Equity	240.81	203.01	164.63	125.56	98.74
Shareholders' Equity	240.81	203.01	164.63	125.56	98.74
Total Liabilities & Equity	271.75	231.12	193.71	143.95	108.57
Total Debt	0.53	0.88	1	1.26	1.3
Net Cash (Debt)	223.58	182.99	155.81	120.25	81.39
Net Cash Growth	22.18%	17.44%	29.57%	47.75%	24.39%
Net Cash Per Share	4.44	3.59	3.01	2.32	1.59
Filing Date Shares Outstanding	50.12	50.08	49.41	49.41	49.41
Total Common Shares Outstanding	50.12	50.08	49.41	49.41	49.41
Working Capital	235.76	196.85	164.12	126.85	94.14
Book Value Per Share	4.80	4.05	3.33	2.54	2.00
Tangible Book Value	240.62	202.83	164.45	125.37	98.55
Tangible Book Value Per Share	4.80	4.05	3.33	2.54	1.99
Land	5.02	4.97	-	-	-
Machinery	2.19	1.94	1.53	1.33	0.82
Leasehold Improvements	1.99	1.99	1.89	1.25	1.25

Source: S&P Global Market Intelligence. Standard template. Financial Sources.